Loading...
Products:Epigenetics and Nuclear Signaling >> DNA / RNA >> Translation >> Regulation
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-eIF4G1 (phospho S1108) antibody
See all eIF4G1 products (11) ...
Rabbit polyclonal to eIF4G1 (phospho S1108)
Reacts with
Human
Predicted to work with
Rabbit
Synthetic peptide (Human) derived from the region of human eIF-4G that contains serine 1108.
Hek293 cells.
Liquid
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Preservative: 0.05% Sodium Azide
Constituents: 50% Glycerol, Dulbecco's phosphate buffered saline (without Mg2+ and Ca2+), 1mg/ml BSA (IgG, protease free) as a carrier. pH 7.3
Concentration information loading...
Immunogen affinity purified
Purified from rabbit serum by sequential epitope-specific chromatography. The antibody has been negatively preadsorbed using a non-phosphopeptide corresponding to the site of phosphorylation to remove antibody that is reactive with non-phosphorylated eIF-4G. The final product is generated by affinity chromatography using a eIF-4G derived peptide that is phosphorylated at serine 1108.
Polyclonal
IgG
Western blot - eIF4G1 (phospho S1108) antibody (ab4772)
(enlarge)
Our Abpromise guarantee covers the use of ab4772 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: 1/1000. Detects a band of approximately 220 kDa (predicted molecular weight: 200 kDa).
Component of the protein complex eIF4F, which is involved in the recognition of the mRNA cap, ATP-dependent unwinding of 5'-terminal secondary structure and recruitment of mRNA to the ribosome.
Defects in EIF4G1 are the cause of Parkinson disease type 18 (PARK18) [MIM:614251]. An autosomal dominant, late-onset form of Parkinson disease. Parkinson disease is a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain.
Belongs to the eIF4G family.
Contains 1 MI domain.
Contains 1 MIF4G domain.
Contains 1 W2 domain.
Phosphorylated at multiple sites in vivo. Phosphorylation at Ser-1185 by PRKCA induces binding to MKNK1.
Following infection by certain enteroviruses, rhinoviruses and aphthoviruses, EIF4G1 is cleaved by the viral protease 2A, or the leader protease in the case of aphthoviruses. This shuts down the capped cellular mRNA transcription.
Target information above from: UniProt accessionQ04637
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - eIF4G1 (phospho S1108) antibody (ab4772)

Predicted band size : 200 kDa
Peptide Competition: Extracts prepared from Hek293 cells were resolved on a 10% polyacrylamide gel and transferred to PVDF. Membranes were either treated with lambda phosphatase (5) or untreated (1-4, 6), were blocked with a 3% non-fat milk-TBST buffer overnight at 4oC, then were incubated with 1.0 µg/mL ab4772 antibody for two hours at room temperature in a 3% non-fat milk-TBST buffer, following its prior incubation with the phosphopeptide immunogen (1), no peptide (2, 5, 6), the non phosphopeptide corresponding to the immunogen (3), or, a generic phosphoserine containing peptide (4). After washing, membranes were incubated with goat F(ab')2 anti-rabbit IgG alkaline phosphatase and the signal was detected using the Tropix WesternStar method. The data show that only the phosphopeptide corresponding to ab4772 blocks the antibody signal, demonstrating the specificity of the antibody. The data also show that phosphatase treatment eliminates the signal, verifying that the antibody is phosphospecific.
ab4772 has not yet been referenced specifically in any publications.
Publishing research using ab4772? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

Peptide Competition: Extracts prepared from Hek293 cells were resolved on a 10% polyacrylamide gel and transferred to PVDF. Membranes were either treated with lambda phosphatase (5) or untreated (1-4, 6), were blocked with a 3% non-fat milk-TBST buffer overnight at 4oC, then were incubated with 1.0
Peptide Competition: Extracts prepared from Hek293 cells were resolved on a 10% polyacrylamide gel and transferred to PVDF. Membranes were either treated with lambda phosphatase (5) or untreated (1-4, 6), were blocked with a 3% non-fat milk-TBST buffer overnight at 4oC, then were incubated with 1.0 µg/mL ab4772 antibody for two hours at room temperature in a 3% non-fat milk-TBST buffer, following its prior incubation with the phosphopeptide immunogen (1), no peptide (2, 5, 6), the non phosphopeptide corresponding to the immunogen (3), or, a generic phosphoserine containing peptide (4). After washing, membranes were incubated with goat F(ab')2 anti-rabbit IgG alkaline phosphatase and the signal was detected using the Tropix WesternStar method. The data show that only the phosphopeptide corresponding to ab4772 blocks the antibody signal, demonstrating the specificity of the antibody. The data also show that phosphatase treatment eliminates the signal, verifying that the antibody is phosphospecific.
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
